BL 1249
| 中文名称 | BL 1249 |
|---|---|
| 中文同义词 | 化合物 T14666;化合物BL-1249;BL 1249,K2P2.1(TREK-1)和K2P10.1(TREK-2)激活剂;化合物BL-1249,10 MM DMSO 溶液 |
| 英文名称 | BL-1249 |
| 英文同义词 | 5,6,7,8-Tetrahydro-N-[2-(2H-tetrazol-5-yl)phenyl]-1-naphthalenamine;1-Naphthalenamine, 5,6,7,8-tetrahydro-N-[2-(2H-tetrazol-5-yl)phenyl]-;BL-1249, 10 mM in DMSO |
| CAS号 | 18200-13-0 |
| 分子式 | C17H17N5 |
| 分子量 | 291.35 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 18200-13-0.mol |
| 结构式 |  |
BL 1249 性质
| 沸点 | 492.6±55.0 °C(Predicted) |
|---|---|
| 密度 | 1.291±0.06 g/cm3(Predicted) |
| 储存条件 | -20°C |
| 溶解度 | 二甲基亚砜：~17.5mg/mL |
| 形态 | 固体 |
| 酸度系数(pKa) | 4.10±0.10(Predicted) |
| 颜色 | 粉色至棕色 |
| InChI | InChI=1S/C17H17N5/c1-2-8-13-12(6-1)7-5-11-15(13)18-16-10-4-3-9-14(16)17-19-21-22-20-17/h3-5,7,9-11,18H,1-2,6,8H2,(H,19,20,21,22) |
| InChIKey | YYNRZIFBTOUICE-UHFFFAOYSA-N |
| SMILES | C1(NC2=CC=CC=C2C2=NNN=N2)=C2C(CCCC2)=CC=C1 |
EC50: 5.5 μM (TREK-1) and 8.0 μM (TREK-2)
BL-1249 produces a concentration-dependent membrane hyperpolarization of cultured human bladder myocytes, assessed as either a reduction in fluorescence of the voltage-sensitive dye bis-(1,2-dibutylbarbituric acid)trimethine oxonol (
EC
50
of 1.26 μM) or by direct electrophysiological measurement
EC
50
of 1.49 μM). BL-1249 produced a concentration-dependent hyperpolarization with an
EC
50
of 21.0 μM in human aortic smooth muscle cells.
In in vitro organ bath experiments, BL-1249 produces a concentration-dependent relaxation of 30 mM KCl-induced contractions in rat bladder strips (
EC
50
of 1.12 μM), yet has no effect on aortic strips up to the highest concentration tested (10 μM). The bladder relaxation produced by BL-1249 is partially blocked by Ba
2+
(1 and 10 mM).
BL-1249 is a selective agonist of the TREK subfamily when applied extracellularly, having preferential action on K
2P
2.1(TREK-1) and K
2P
10.1(TREK-2) over K
2P
4.1(TRAAK) and establish that its mechanism of action relies on gating at the selectivity filter C-type gate.
BL-1249 (1 mg/kg) inhibits isovolumic bladder contractions in vivo. The short duration of the effect of BL-1249 on bladder contraction ( 30 min) is likely due to a fast elimination half-life of the compound after i.v. administration (0.69 h).
BL-1249 (1 mg/kg) has little effect on mean arterial blood pressure, an observation again consistent with the in vitro bladder to vascular relaxant selectivity.